Clinical impact of proteinuria on renal function and treatment outcomes in patients with radioiodine-refractory thyroid cancer treated with lenvatinib

Clinical impact of proteinuria on renal function and treatment outcomes in patients with radioiodine-refractory thyroid cancer treated with lenvatinib

Proteinuria has been described as a major on-target adverse event of lenvatinib, although its long-term impact on renal function and clinical outcomes remains unclear. We conducted a retrospective observational study to assess renal function and prognosis in patients with radioiodine-refractory diff...

Full description

Saved in:
Bibliographic Details
Main Authors: Naoki Fukuda, Kazuhisa Toda, Hirotaka Suto, Ryosuke Oki, Xiaofei Wang, Tetsuya Urasaki, Yasuyoshi Sato, Kenji Nakano, Makiko Ono, Junichi Tomomatsu, Hiroki Mitani, Shunji Takahashi
Format: Article
Language:English
Published: The Japan Endocrine Society 2024-04-01
Series:Endocrine Journal
Subjects:
differentiated thyroid cancer
lenvatinib
proteinuria
Online Access:https://www.jstage.jst.go.jp/article/endocrj/71/4/71_EJ23-0378/_html/-char/en
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://www.jstage.jst.go.jp/article/endocrj/71/4/71_EJ23-0378/_html/-char/en

Similar Items